Literature DB >> 3043926

Cardiac effects of cocaine: a review.

A H Gradman1.   

Abstract

Over the past 15 years, there has been a dramatic increase in the abuse of purified cocaine preparations throughout the industrialized world. The potential lethality of the drug is now recognized, and a growing series of case reports indicate that cardiotoxicity may be an important factor in the morbidity and mortality associated with the drug. Acute myocardial infarction is a demonstrated risk both in subjects with and without pre-existent coronary artery disease. The arrhythmogenic potential of cocaine is less clear and appears to have been overemphasized, although several documented cases of ventricular arrhythmia following cocaine use have been reported. Cardiomyopathy and myocarditis associated with cocaine have also been described, but an etiologic relationship is presently inferential. Based upon presumed pathophysiologic mechanisms, beta adrenergic blocking agents are recommended for arrhythmias, and calcium channel blocking agents and/or nitrates for ischemic syndromes related to cocaine. It is emphasized that these recommendations are based upon a paucity of relevant clinical studies, and controlled clinical trials to establish their efficacy have not been performed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3043926      PMCID: PMC2590300     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  31 in total

1.  Acute myocardial infarction shortly after cocaine inhalation.

Authors:  J L Rod; R P Zucker
Journal:  Am J Cardiol       Date:  1987-01-01       Impact factor: 2.778

2.  Cocaine-induced myocardial infarction.

Authors:  I M Rollingher; A S Belzberg; I L Macdonald
Journal:  CMAJ       Date:  1986-07-01       Impact factor: 8.262

3.  Pheochromocytoma masquerading as a cardiomyopathy.

Authors:  R Garcia; J M Jennings
Journal:  Am J Cardiol       Date:  1972-04       Impact factor: 2.778

4.  Anaesthesia for laryngoscopy. A comparison of the cardiovascular effects of cocaine and lignocaine.

Authors:  D Orr; I Jones
Journal:  Anaesthesia       Date:  1968-04       Impact factor: 6.955

5.  Dilated cardiomyopathy and cocaine abuse. Report of two cases.

Authors:  R S Wiener; J T Lockhart; R G Schwartz
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

Review 6.  Cocaine-associated myocardial ischemia. Review of clinical and angiographic findings.

Authors:  D W Mathias
Journal:  Am J Med       Date:  1986-10       Impact factor: 4.965

7.  Acute cardiac events temporally related to cocaine abuse.

Authors:  J M Isner; N A Estes; P D Thompson; M R Costanzo-Nordin; R Subramanian; G Miller; G Katsas; K Sweeney; W Q Sturner
Journal:  N Engl J Med       Date:  1986-12-04       Impact factor: 91.245

8.  Recurrent myocardial infarction associated with cocaine abuse in a young man with normal coronary arteries: evidence for coronary artery spasm culminating in thrombosis.

Authors:  F H Zimmerman; G M Gustafson; H G Kemp
Journal:  J Am Coll Cardiol       Date:  1987-04       Impact factor: 24.094

9.  Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes.

Authors:  R B Resnick; R S Kestenbaum; L K Schwartz
Journal:  Science       Date:  1977-02-18       Impact factor: 47.728

10.  Pathogenesis of cocaine-induced ischemic heart disease. Autopsy findings in a 21-year-old man.

Authors:  R W Simpson; W D Edwards
Journal:  Arch Pathol Lab Med       Date:  1986-06       Impact factor: 5.534

View more
  10 in total

Review 1.  Troponin I in the intensive care unit setting: from the heart to the heart.

Authors:  Chiara Lazzeri; Manuela Bonizzoli; Giovanni Cianchi; Gian Franco Gensini; Adriano Peris
Journal:  Intern Emerg Med       Date:  2008-03-07       Impact factor: 3.397

2.  Effects of intranasal cocaine on sympathetic nerve discharge in humans.

Authors:  T N Jacobsen; P A Grayburn; R W Snyder; J Hansen; B Chavoshan; C Landau; R A Lange; L D Hillis; R G Victor
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  Cocaine and the heart.

Authors:  M Egred; G K Davis
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

4.  Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users.

Authors:  Hong Lai; Elliot K Fishman; Gary Gerstenblith; Jeffrey A Brinker; Wenjing Tong; Sandeepan Bhatia; Barbara Detrick; Shenghan Lai
Journal:  Int J Cardiol       Date:  2011-02-03       Impact factor: 4.164

5.  Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene.

Authors:  E F McCance-Katz; L H Price; C J McDougle; T R Kosten; J E Black; P I Jatlow
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Is cocaine use recognised as a risk factor for acute coronary syndrome by doctors in the UK?

Authors:  David M Wood; Duncan Hill; Awini Gunasekera; Shaun L Greene; Alison L Jones; Paul I Dargan
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

7.  Hepatitis C virus infection and the risk of coronary disease.

Authors:  Adeel A Butt; Wang Xiaoqiang; Matthew Budoff; David Leaf; Lewis H Kuller; Amy C Justice
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

Review 8.  Cocaine, cardiomyopathy, and heart failure: a systematic review and meta-analysis.

Authors:  Daniel J Arenas; Sourik Beltran; Sara Zhou; Lee R Goldberg
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

9.  Cocaine alters heart rate dynamics in conscious ferrets.

Authors:  B S Stambler; J P Morgan; J Mietus; G B Moody; A L Goldberger
Journal:  Yale J Biol Med       Date:  1991 Mar-Apr

10.  Memory-Focused Cognitive Therapy for Cocaine Use Disorder: Theory, Procedures and Preliminary Evidence From an External Pilot Randomised Controlled Trial.

Authors:  John Marsden; Camille Goetz; Tim Meynen; Luke Mitcheson; Garry Stillwell; Brian Eastwood; John Strang; Nick Grey
Journal:  EBioMedicine       Date:  2018-02-02       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.